Literature DB >> 33537941

Natural Cannabinoids as Templates for Sleep Disturbances Treatments.

Eric Murillo-Rodríguez1,2, Sérgio Machado3,4,5,6, Claudio Imperatori3,7, Tetsuya Yamamoto3,8, Henning Budde3,9.   

Abstract

The sleep-wake cycle is a complex composition of specific physiological and behavioral characteristics. In addition, neuroanatomical, neurochemical and molecular systems exerts influences in the modulation of the sleep-wake cycle. Moreover, homeostatic and circadian mechanisms interact to control the waking or sleeping states. As many other behaviors, sleep also develops pathological features that include several signs and symptoms corresponding to medical conditions known as sleep disorders.In addition to the neurobiological mechanisms modulating sleep, external elements also influence the sleep-wake cycle, including the use of Cannabis sativa (C. sativa). In this regard, and over the last decades, the interest of studying the pharmacology of Δ9-tetrahydrocannabinol (Δ9-THC), the principal psychoactive constituent of C. sativa, has been addressed. Moreover, in recent years, the focus of scientific interest has moved on to studying the second plant constituent with non-psychotropic pharmacological properties: Cannabidiol (CBD).The pharmacological and pharmaceutical interest of CBD has been focus of attention due to the accumulating body of evidence regarding the positive outcomes of using CBD for the treatment of several health issues, such as psychiatric and neurodegenerative disorders, epilepsy, etc. Since the most prominent sleep disruptions include excessive daytime sleepiness (EDS), current treatments include the use of drugs such as stimulants of antidepressants. Notwithstanding, side effects are commonly reported among the patients under prescription of these compounds. Thus, the search of novelty therapeutical approaches aimed to treat ESD may consider the use of cannabinoid-derived compounds, such as CBD. In this chapter, we will show experimental evidence regarding the potential role of CBD as a wake-inducing compound aimed to manage EDS.

Entities:  

Keywords:  Cannabis sativa; Disturbance; Drug; Medical; Wakefulness

Year:  2021        PMID: 33537941     DOI: 10.1007/978-3-030-61663-2_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  77 in total

Review 1.  Basal Forebrain Cholinergic System and Memory.

Authors:  M G Blake; M M Boccia
Journal:  Curr Top Behav Neurosci       Date:  2018

Review 2.  Cannabis, Cannabinoids, and Sleep: a Review of the Literature.

Authors:  Kimberly A Babson; James Sottile; Danielle Morabito
Journal:  Curr Psychiatry Rep       Date:  2017-04       Impact factor: 5.285

Review 3.  Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America.

Authors:  Ran Abuhasira; Liat Shbiro; Yuval Landschaft
Journal:  Eur J Intern Med       Date:  2018-01-10       Impact factor: 4.487

Review 4.  Current and future developments in the field of central sleep apnoea.

Authors:  Tarek Bekfani; William T Abraham
Journal:  Europace       Date:  2016-05-26       Impact factor: 5.214

Review 5.  Pharmacotherapy for residual excessive sleepiness and cognition in CPAP-treated patients with obstructive sleep apnea syndrome: A systematic review and meta-analysis.

Authors:  Ariane B C C Avellar; Luciane B C Carvalho; Gilmar F Prado; Lucila B F Prado
Journal:  Sleep Med Rev       Date:  2015-10-28       Impact factor: 11.609

6.  Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats.

Authors:  Marcos Hortes N Chagas; José Alexandre S Crippa; Antonio Waldo Zuardi; Jaime E C Hallak; João Paulo Machado-de-Sousa; Camila Hirotsu; Lucas Maia; Sergio Tufik; Monica Levy Andersen
Journal:  J Psychopharmacol       Date:  2013-01-23       Impact factor: 4.153

Review 7.  In the Clinic. Restless Legs Syndrome.

Authors:  Suzanne Bertisch
Journal:  Ann Intern Med       Date:  2015-11-03       Impact factor: 25.391

Review 8.  Cannabidiol as a Potential Treatment for Anxiety Disorders.

Authors:  Esther M Blessing; Maria M Steenkamp; Jorge Manzanares; Charles R Marmar
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 9.  New developments in the management of narcolepsy.

Authors:  Vivien C Abad; Christian Guilleminault
Journal:  Nat Sci Sleep       Date:  2017-03-03

Review 10.  Sleep-Active Neurons: Conserved Motors of Sleep.

Authors:  Henrik Bringmann
Journal:  Genetics       Date:  2018-04       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.